AUS
NZ
UK
CA
USA
IND
Archer Materials Limited (ASX:AXE) has finalized binding commitments for a $7.0 million placement conducted in two tranches and has launched a $3 million Share Purchase Plan (SPP) as it advances a three-year strategic partnership with IonQ, a global leader in quantum computing. The placement, priced at A$0.27 per share, garnered strong interest from new institutional investors and will directly fund Archer’s goal of developing sovereign quantum computing capabilities within Australia. This capital raise follows Archer’s announcement on 1 July 2026 confirming its collaboration with IonQ, which grants the Adelaide-based company access to the IonQ Quantum Cloud for creating quantum algorithms, applications, and solutions. Combined, the placement and SPP could raise up to $10 million before costs, positioning Archer as a key player in Australia’s emerging quantum technology sector.<\/p> <\/div>
Key Points<\/h3>
- Company: Archer Materials Limited (ASX:AXE), headquartered at Lot Fourteen, Frome Road, Adelaide SA 5000<\/li>
- Binding commitments secured for a $7.0 million two-tranche placement issuing approximately 25.9 million new fully paid ordinary shares at A$0.27 each<\/li>
- Three-year strategic partnership with IonQ provides Archer access to the IonQ Quantum Cloud for quantum algorithm, application, and solution development<\/li>
- SPP offered at the same A$0.27 price aims to raise up to $3 million from eligible shareholders in Australia and New Zealand<\/li>
- Participants in both placement and SPP receive one free attaching option per new share, exercisable at A$0.35 and expiring 30 June 2029, pending shareholder approval at an EGM anticipated in mid-August 2026<\/li>
- Tranche 1 settlement is scheduled for 8 July 2026; Tranche 2 settlement and option issuance depend on EGM approval expected mid-August 2026<\/li>
- Investors should monitor the mid-August 2026 EGM outcome and the start of IonQ program activities as upcoming milestones<\/li>
<\/ul>
<\/div>
Archer Materials Announces $7 Million Binding Commitments from Institutional and Sophisticated Investors<\/h2>
On 3 July 2026, Archer Materials declared it had secured binding commitments from institutional and sophisticated investors, including its Board and Management, to raise A$7.0 million before costs via a non-underwritten two-tranche placement. This involves issuing approximately 25.9 million new fully paid ordinary shares at A$0.27 each. Bell Potter Securities Limited acted as sole lead manager and bookrunner, while Piper Alderman Lawyers provided legal counsel.<\/p>
The offer price of A$0.27 per share represents a 12.9% discount to the last closing price of A$0.310 on 30 June 2026 and a 13.6% discount to the five-day volume weighted average price of A$0.312. Shares issued will rank equally with existing shares on a pari passu basis. Archer stated this funding outcome demonstrates investor confidence in its technology direction and team capabilities.<\/p>
Placement Structured in Two Tranches: $6.86 Million Under Listing Rule 7.1 and $0.14 Million Director Participation<\/h2>
The placement is divided into two tranches to comply with ASX Listing Rules on share issuance. Tranche 1 will raise approximately $6.86 million before costs by issuing about 25.4 million shares under Listing Rule 7.1 capacity, with settlement scheduled for 8 July 2026 and allotment on 9 July 2026.<\/p>
Tranche 2 involves a $0.14 million placement to Directors and Management, issuing roughly 0.52 million shares, subject to shareholder approval at an Extraordinary General Meeting (EGM) expected in mid-August 2026. Director and Management participation will be on identical terms and pricing as other investors, ensuring alignment with shareholder interests.<\/p>
Attaching Options at A$0.35 Expiring June 2029 Offered to Placement and SPP Participants<\/h2>
A key feature of both the placement and SPP is the inclusion of attaching options. Each participant will receive one free unquoted attaching option per new share issued. These options have an exercise price of A$0.35 and expire on 30 June 2029, offering a three-year window to exercise at a price above the current offer.<\/p>
Issuance of these options is conditional on shareholder approval at the forthcoming EGM, anticipated in mid-August 2026. Additionally, subject to the same approval, Bell Potter Securities Limited will be issued approximately 5.6 million unquoted options on identical terms as part of its lead manager agreement. These options represent a significant portion of the capital structure, making the EGM vote a critical event for investors.<\/p>
Three-Year Strategic Partnership with IonQ Grants Archer Access to IonQ Quantum Cloud for Development<\/h2>
The capital raise is directly linked to Archer’s strategic agreement with IonQ, announced on 1 July 2026. This three-year partnership provides Archer access to the IonQ Quantum Cloud, enabling development of quantum algorithms, applications, and solutions. Archer described this agreement as central to its strategy to establish sovereign quantum computing capabilities in Australia.<\/p>
The partnership marks a major advancement for Archer’s commercial quantum program by providing infrastructure that would otherwise require independent development. Access to the IonQ Quantum Cloud is expected to accelerate Archer’s engagement with clients and progress in quantum machine learning (QML), key areas outlined in the company’s use-of-funds disclosure. Execution of the IonQ agreement is set to begin now that funding is secured.<\/p>
Allocation of Up to $10 Million Raised Across Quantum, Biochip, and Working Capital Initiatives<\/h2>
Archer outlined that funds raised from the placement and SPP, net of expenses, will primarily support quantum programs including IonQ client and project development, QML development, and qubit development. These initiatives form the core technology pathway enabled by the IonQ partnership and the sovereign quantum computing initiative.<\/p>
In addition to quantum efforts, the company will continue investing in biochip and advanced materials technologies, indicating the IonQ partnership complements rather than replaces other programs. General working capital needs are also covered. While no specific dollar breakdown was provided in this update, further details are available in the investor presentation lodged with ASX on 3 July 2026.<\/p>
$3 Million Share Purchase Plan Opens to Eligible Australian and New Zealand Shareholders at A$0.27 Per Share<\/h2>
Alongside the institutional placement, Archer launched a non-underwritten SPP targeting up to $3 million from eligible retail shareholders. The SPP is open to shareholders with registered addresses in Australia or New Zealand as of 7:00pm Sydney time on 2 July 2026 (the record date). Each eligible shareholder may apply for up to A$30,000 worth of shares at the same A$0.27 offer price.<\/p>
The SPP is subject to scale back and must comply with ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547. Participants will also receive one attaching option per new share on the same terms as placement participants, pending EGM approval. Full terms and application details will be provided in a separate offer document. No closing date for the SPP was disclosed in this update.<\/p>
CEO Dr Simon Ruffell Highlights Funding as Validation of Archer’s Quantum Strategy and Sovereign Capability Ambitions<\/h2>
Dr Simon Ruffell, Archer’s CEO, remarked on the capital raise’s significance: "The strong support we have received through this equity raising is a clear endorsement of Archer's quantum strategy. This funding positions Archer to execute the strategic agreement with IonQ and advance the Company's other projects to the next stage. This outcome reflects investors' confidence in our technology and our team's capability to advance our business and quantum technologies."<\/p>
He added, "With funding now secured, we can commence our plan to establish sovereign quantum computing capability in Australia." His comments link the capital raise directly to IonQ agreement execution and frame sovereign quantum computing as a national priority. Investors will likely watch how quickly Archer translates this funding into program milestones.<\/p>
Strategic Importance of Archer’s IonQ Partnership for Sovereign Quantum Computing in Australia<\/h2>
Sovereign quantum computing capability—domestic control over quantum computing infrastructure—is increasingly significant for Australia’s technology and national security interests. Archer’s IonQ agreement fits within this context, accelerating its strategy to build sovereign capability. Archer’s headquarters at the Lot Fourteen precinct in Adelaide is a recognized innovation hub connected to Australia’s technology and defense sectors.<\/p>
By partnering with IonQ, a leading publicly listed quantum computing company, Archer aims to leverage global quantum infrastructure to develop local expertise and commercial solutions. The company’s planned use of funds across IonQ client and project development, QML, and qubit development indicates a layered quantum program targeting both near-term commercial applications and long-term hardware capabilities. This positions Archer as one of Australia’s most active publicly listed quantum technology participants.<\/p>
Placement Timeline and EGM Approvals to Watch Through Mid-August 2026<\/h2>
The placement timetable outlines key near-term milestones. Following the capital raising announcement and trading halt lift on 3 July 2026, Tranche 1 settlement is scheduled for 8 July 2026, with allotment on 9 July 2026. These dates are subject to legal and ASX Listing Rule compliance and may change at the company’s discretion.<\/p>
The EGM, expected mid-August 2026, is crucial for approving Tranche 2 settlement, issuance of attaching options to placement and SPP participants, and lead manager options to Bell Potter Securities Limited. Investors should look for EGM date confirmation and the release of the notice of meeting detailing resolutions for shareholder voting.<\/p>
Capital Raise Structure Reflects Archer’s Focus on Execution and Shareholder Inclusion<\/h2>
The capital raise combines an institutional placement with a retail SPP and attaching options, balancing rapid execution with broad shareholder participation. Utilizing Listing Rule 7.1 capacity for most of the placement allows Tranche 1 shares to be issued and funds received promptly, enabling immediate IonQ-related activities. The SPP offers existing retail shareholders in Australia and New Zealand the chance to participate on equal terms.<\/p>
Attaching options exercisable at A$0.35 through 30 June 2029 provide potential upside beyond the offer price and may incentivize participation given the discount to market price. The company did not disclose its total cash position post-raise in this update but referenced the investor presentation lodged on 3 July 2026 for further details. The immediate share price impact was unclear at the time due to a trading halt. Investors will likely monitor market reaction to the IonQ partnership narrative alongside dilution effects when trading resumes.<\/p>
Archer Materials Announces $7 Million Binding Commitments from Institutional and Sophisticated Investors<\/h2>
On 3 July 2026, Archer Materials declared it had secured binding commitments from institutional and sophisticated investors, including its Board and Management, to raise A$7.0 million before costs via a non-underwritten two-tranche placement. This involves issuing approximately 25.9 million new fully paid ordinary shares at A$0.27 each. Bell Potter Securities Limited acted as sole lead manager and bookrunner, while Piper Alderman Lawyers provided legal counsel.<\/p>
The offer price of A$0.27 per share represents a 12.9% discount to the last closing price of A$0.310 on 30 June 2026 and a 13.6% discount to the five-day volume weighted average price of A$0.312. Shares issued will rank equally with existing shares on a pari passu basis. Archer stated this funding outcome demonstrates investor confidence in its technology direction and team capabilities.<\/p>
Placement Structured in Two Tranches: $6.86 Million Under Listing Rule 7.1 and $0.14 Million Director Participation<\/h2>
The placement is divided into two tranches to comply with ASX Listing Rules on share issuance. Tranche 1 will raise approximately $6.86 million before costs by issuing about 25.4 million shares under Listing Rule 7.1 capacity, with settlement scheduled for 8 July 2026 and allotment on 9 July 2026.<\/p>
Tranche 2 involves a $0.14 million placement to Directors and Management, issuing roughly 0.52 million shares, subject to shareholder approval at an Extraordinary General Meeting (EGM) expected in mid-August 2026. Director and Management participation will be on identical terms and pricing as other investors, ensuring alignment with shareholder interests.<\/p>
Attaching Options at A$0.35 Expiring June 2029 Offered to Placement and SPP Participants<\/h2>
A key feature of both the placement and SPP is the inclusion of attaching options. Each participant will receive one free unquoted attaching option per new share issued. These options have an exercise price of A$0.35 and expire on 30 June 2029, offering a three-year window to exercise at a price above the current offer.<\/p>
Issuance of these options is conditional on shareholder approval at the forthcoming EGM, anticipated in mid-August 2026. Additionally, subject to the same approval, Bell Potter Securities Limited will be issued approximately 5.6 million unquoted options on identical terms as part of its lead manager agreement. These options represent a significant portion of the capital structure, making the EGM vote a critical event for investors.<\/p>
Three-Year Strategic Partnership with IonQ Grants Archer Access to IonQ Quantum Cloud for Development<\/h2>
The capital raise is directly linked to Archer’s strategic agreement with IonQ, announced on 1 July 2026. This three-year partnership provides Archer access to the IonQ Quantum Cloud, enabling development of quantum algorithms, applications, and solutions. Archer described this agreement as central to its strategy to establish sovereign quantum computing capabilities in Australia.<\/p>
The partnership marks a major advancement for Archer’s commercial quantum program by providing infrastructure that would otherwise require independent development. Access to the IonQ Quantum Cloud is expected to accelerate Archer’s engagement with clients and progress in quantum machine learning (QML), key areas outlined in the company’s use-of-funds disclosure. Execution of the IonQ agreement is set to begin now that funding is secured.<\/p>
Allocation of Up to $10 Million Raised Across Quantum, Biochip, and Working Capital Initiatives<\/h2>
Archer outlined that funds raised from the placement and SPP, net of expenses, will primarily support quantum programs including IonQ client and project development, QML development, and qubit development. These initiatives form the core technology pathway enabled by the IonQ partnership and the sovereign quantum computing initiative.<\/p>
In addition to quantum efforts, the company will continue investing in biochip and advanced materials technologies, indicating the IonQ partnership complements rather than replaces other programs. General working capital needs are also covered. While no specific dollar breakdown was provided in this update, further details are available in the investor presentation lodged with ASX on 3 July 2026.<\/p>
$3 Million Share Purchase Plan Opens to Eligible Australian and New Zealand Shareholders at A$0.27 Per Share<\/h2>
Alongside the institutional placement, Archer launched a non-underwritten SPP targeting up to $3 million from eligible retail shareholders. The SPP is open to shareholders with registered addresses in Australia or New Zealand as of 7:00pm Sydney time on 2 July 2026 (the record date). Each eligible shareholder may apply for up to A$30,000 worth of shares at the same A$0.27 offer price.<\/p>
The SPP is subject to scale back and must comply with ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547. Participants will also receive one attaching option per new share on the same terms as placement participants, pending EGM approval. Full terms and application details will be provided in a separate offer document. No closing date for the SPP was disclosed in this update.<\/p>
CEO Dr Simon Ruffell Highlights Funding as Validation of Archer’s Quantum Strategy and Sovereign Capability Ambitions<\/h2>
Dr Simon Ruffell, Archer’s CEO, remarked on the capital raise’s significance: "The strong support we have received through this equity raising is a clear endorsement of Archer's quantum strategy. This funding positions Archer to execute the strategic agreement with IonQ and advance the Company's other projects to the next stage. This outcome reflects investors' confidence in our technology and our team's capability to advance our business and quantum technologies."<\/p>
He added, "With funding now secured, we can commence our plan to establish sovereign quantum computing capability in Australia." His comments link the capital raise directly to IonQ agreement execution and frame sovereign quantum computing as a national priority. Investors will likely watch how quickly Archer translates this funding into program milestones.<\/p>
Strategic Importance of Archer’s IonQ Partnership for Sovereign Quantum Computing in Australia<\/h2>
Sovereign quantum computing capability—domestic control over quantum computing infrastructure—is increasingly significant for Australia’s technology and national security interests. Archer’s IonQ agreement fits within this context, accelerating its strategy to build sovereign capability. Archer’s headquarters at the Lot Fourteen precinct in Adelaide is a recognized innovation hub connected to Australia’s technology and defense sectors.<\/p>
By partnering with IonQ, a leading publicly listed quantum computing company, Archer aims to leverage global quantum infrastructure to develop local expertise and commercial solutions. The company’s planned use of funds across IonQ client and project development, QML, and qubit development indicates a layered quantum program targeting both near-term commercial applications and long-term hardware capabilities. This positions Archer as one of Australia’s most active publicly listed quantum technology participants.<\/p>
Placement Timeline and EGM Approvals to Watch Through Mid-August 2026<\/h2>
The placement timetable outlines key near-term milestones. Following the capital raising announcement and trading halt lift on 3 July 2026, Tranche 1 settlement is scheduled for 8 July 2026, with allotment on 9 July 2026. These dates are subject to legal and ASX Listing Rule compliance and may change at the company’s discretion.<\/p>
The EGM, expected mid-August 2026, is crucial for approving Tranche 2 settlement, issuance of attaching options to placement and SPP participants, and lead manager options to Bell Potter Securities Limited. Investors should look for EGM date confirmation and the release of the notice of meeting detailing resolutions for shareholder voting.<\/p>
Capital Raise Structure Reflects Archer’s Focus on Execution and Shareholder Inclusion<\/h2>
The capital raise combines an institutional placement with a retail SPP and attaching options, balancing rapid execution with broad shareholder participation. Utilizing Listing Rule 7.1 capacity for most of the placement allows Tranche 1 shares to be issued and funds received promptly, enabling immediate IonQ-related activities. The SPP offers existing retail shareholders in Australia and New Zealand the chance to participate on equal terms.<\/p>
Attaching options exercisable at A$0.35 through 30 June 2029 provide potential upside beyond the offer price and may incentivize participation given the discount to market price. The company did not disclose its total cash position post-raise in this update but referenced the investor presentation lodged on 3 July 2026 for further details. The immediate share price impact was unclear at the time due to a trading halt. Investors will likely monitor market reaction to the IonQ partnership narrative alongside dilution effects when trading resumes.<\/p>
